CHD6
Chromodomain-helicase-DNA-binding protein 6
Also known as: CHD5, CHD6_HUMAN, dJ620E11.1, FLJ22369, KIAA1335, RIGB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TD26
- Gene
- CHD6
- Ensembl
- ENSG00000124177
- Chromosome
- 20
- Canonical length
- 2715 aa
- Protein class
- Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the SNF2/RAD54 helicase protein family. The encoded protein contains two chromodomains, a helicase domain, and an ATPase domain. Several multi-subunit protein complexes remodel chromatin to allow patterns of cell type-specific gene expression, and the encoded protein is thought to be a core member of one or more of these chromatin remodeling complexes. The encoded protein may function as a transcriptional repressor and is involved in the cellular repression of influenza virus replication. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
2715 residues, UniProt reviewed canonical sequence.
>Q8TD26|CHD6
1 MKMKIQKKEK QLSNLKVLNH SPMSDASVNF DYKSPSPFDC STDQEEKIED VASHCLPQKD
61 LYTAEEEAAT LFPRKMTSHN GMEDSGGGGT GVKKKRKKKE PGDQEGAAKG SKDREPKPKR
121 KREPKEPKEP RKAKEPKKAK EHKEPKQKDG AKKARKPREA SGTKEAKEKR SCTDSAARTK
181 SRKASKEQGP TPVEKKKKGK RKSETTVESL ELDQGLTNPS LRSPEESTES TDSQKRRSGR
241 QVKRRKYNED LDFKVVDDDG ETIAVLGAGR TSALSASTLA WQAEEPPEDD ANIIEKILAS
301 KTVQEVHPGE PPFDLELFYV KYRNFSYLHC KWATMEELEK DPRIAQKIKR FRNKQAQMKH
361 IFTEPDEDLF NPDYVEVDRI LEVAHTKDAE TGEEVTHYLV KWCSLPYEES TWELEEDVDP
421 AKVKEFESLQ VLPEIKHVER PASDSWQKLE KSREYKNSNQ LREYQLEGMN WLLFNWYNRK
481 NCILADEMGL GKTIQSITFL SEIFLRGIHG PFLIIAPLST ITNWEREFRT WTEMNAIVYH
541 GSQISRQMIQ QYEMVYRDAQ GNPLSGVFKF HVVITTFEMI LADCPELKKI HWSCVIIDEA
601 HRLKNRNCKL LEGLKLMALE HKVLLTGTPL QNSVEELFSL LNFLEPSQFP SETAFLEEFG
661 DLKTEEQVKK LQSILKPMML RRLKDDVEKN LAPKQETIIE VELTNIQKKY YRAILEKNFS
721 FLTKGANQHN MPNLINTMME LRKCCNHPYL INGAEEKILE DFRKTHSPDA PDFQLQAMIQ
781 AAGKLVLIDK LLPKLIAGGH KVLIFSQMVR CLDILEDYLI QRRYTYERID GRVRGNLRQA
841 AIDRFCKPDS DRFVFLLCTR AGGLGINLTA ADTCIIFDSD WNPQNDLQAQ ARCHRIGQSK
901 AVKVYRLITR NSYEREMFDK ASLKLGLDKA VLQDINRKGG TNGVQQLSKM EVEDLLRKGA
961 YGALMDEEDE GSKFCEEDID QILQRRTHTI TIQSEGKGST FAKASFVASG NRTDISLDDP
1021 NFWQKWAKIA ELDTEAKNEK ESLVIDRPRV RKQTKHYNSF EEDELMEFSE LDSDSDERPT
1081 RSRRLNDKAR RYLRAECFRV EKNLLIFGWG RWKDILTHGR FKWHLNEKDM EMICRALLVY
1141 CVKHYKGDEK IKSFIWELIT PTKDGQAQTL QNHSGLSAPV PRGRKGKKTK NQLLIPELKD
1201 ADWLATCNPE VVLHDDGYKK HLKQHCNKVL LRVRMLYYLK AEILGEAAEK AFEGSPAREL
1261 DVPLPDIDYM EIPVDWWDAE ADKSLLIGVF KHGYERYNAM RADPALCFLE KVGMPDEKSL
1321 SAEQGVTDGT SDIPERGNTD KEDNAEDKVD GLQKQTESSS DGGDGVFSEK KDDSRAAQDG
1381 SDPDKSPWPV SSALTARLRR LVTVYQRCNR KELCRPEILG PGNQGYWVQE EMFRRTSEMD
1441 LINKEAQKRW TRREQADFYR TVSSFGVVYD QEKKTFDWTQ FRIISRLDKK SDESLEQYFY
1501 SFVAMCRNVC RLPTWKDGGP PDTTIYVEPI TEERAARTLY RIELLRKVRE QVLKCPQLHE
1561 RLQLCRPSLY LPVWWECGKH DRDLLIGTAK HGLNRTDCYI MNDPQLSFLD AYRNYAQHKR
1621 SGTQAPGNLC CLYQTNSKLY ESLTYSQMSR TSESLENEPE NLVRVESRDD HLSLPDVTCE
1681 NFISKVQDVI SINHDESLLP ESLESMMYGK KVLSQEPSSF QESPSTNTES RKDVITISIS
1741 KDGNCQSGGP EAEIASGPTF MGSLEAGGVA QANIKNGKHL LMSISKEGEL CCSEAGQRPE
1801 NIGQLEAKCL ASPSLNPGNE SGFVDMCSLS VCDSKRNLSS DQQLIDLLEN KSLESKLILS
1861 QNHSDEEEEE EENEEENLAM AVGMGERPEV LHLTEPTTNI SREKNQGFQD ETKKGSLEVA
1921 NQTPGLQRAF PAPAACQCHC KHMERWMHGL ENDEFEIEKP KAYIPDLFKS KTNTIAMEGE
1981 PTAIPSQPFK VKHELLKEPW KESAEGQNVF PTYPLEGSEL KSEDMDFENK DDYDRDGNCH
2041 SQDYPGKYSE EESKSSTSGI TGDIGDELQE ARAPTIAQLL QEKTLYSFSE WPKDRVIINR
2101 LDNICHVVLK GKWPSSQQYE PSGTLPTPVL TSSAGSRTSL SEPEAAEHSF SNGAALAAQI
2161 HKESFLAPVF TKDEQKHRRP YEFEVERDAK ARGLEQFSAT HGHTPIILNG WHGESAMDLS
2221 CSSEGSPGAT SPFPVSASTP KIGAISSLQG ALGMDLSGIL QAGLIHPVTG QIVNGSLRRD
2281 DAATRRRRGR RKHVEGGMDL IFLKEQTLQA GILEVHEDPG QATLSTTHPE GPGPATSAPE
2341 PATAASSQAE KSIPSKSLLD WLRQQADYSL EVPGFGANFS DKPKQRRPRC KEPGKLDVSS
2401 LSGEERVPAI PKEPGLRGFL PENKFNHTLA EPILRDTGPR RRGRRPRSEL LKAPSIVADS
2461 PSGMGPLFMN GLIAGMDLVG LQNMRNMPGI PLTGLVGFPA GFATMPTGEE VKSTLSMLPM
2521 MLPGMAAVPQ MFGVGGLLSP PMATTCTSTA PASLSSTTKS GTAVTEKTAE DKPSSHDVKT
2581 DTLAEDKPGP GPFSDQSEPA ITTSSPVAFN PFLIPGVSPG LIYPSMFLSP GMGMALPAMQ
2641 QARHSEIVGL ESQKRKKKKT KGDNPNSHPE PAPSCEREPS GDENCAEPSA PLPAEREHGA
2701 QAGEGALKDS NNDTNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHD6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- thymus: 16 nTPM
- parathyroid gland: 15 nTPM
- retina: 15 nTPM
- bone marrow: 13 nTPM
- thyroid gland: 13 nTPM
- ovary: 13 nTPM
Single-cell type
- choroid plexus epithelial cells: 313 nCPM
- pituitary stem cells: 303 nCPM
- tuft cells: 288 nCPM
- corticotrophs: 283 nCPM
- salivary ionocytes: 274 nCPM
- lactotrophs: 269 nCPM
Immune cell
- basophil: 20 nTPM
- plasmacytoid DC: 11 nTPM
- naive B-cell: 11 nTPM
- NK-cell: 10 nTPM
- non-classical monocyte: 10 nTPM
- naive CD4 T-cell: 9.4 nTPM
Brain region
- cerebellum: 78 nTPM
- pons: 71 nTPM
- hypothalamus: 69 nTPM
- cerebral cortex: 68 nTPM
- white matter: 68 nTPM
- thalamus: 66 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CHD6.
Disease | ImmuneIEDB
Conditions an epitope on CHD6 was assayed in.
- glioblastoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.07
- gnomAD pLI
- 1
- gnomAD missense Z
- 4
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell redox homeostasis
- chromatin remodeling
- positive regulation of transcription by RNA polymerase II
- regulation of gene expression
Molecular functions
- ATP binding
- ATP hydrolysis activity
- ATP-dependent activity, acting on DNA
- ATP-dependent chromatin remodeler activity
- chromatin binding
- DNA binding
- histone binding
- transcription coregulator binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SNF2, N-terminal domain
- Chromo/chromo shadow domain
- Helicase, C-terminal domain-like
- DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site
- BRK domain
- Helicase superfamily 1/2, ATP-binding domain
- Chromo-like domain superfamily
- Chromo domain
- P-loop containing nucleoside triphosphate hydrolase
- BRK domain superfamily
- SNF2-like, N-terminal domain superfamily
- SNF2/RAD5-like, C-terminal helicase domain
- Chromodomain-helicase-DNA-binding
- Chromodomain-helicase-DNA-binding protein 6-9, tri-helical domain
- SNF2-related domain
- Helicase conserved C-terminal domain
- Chromo (CHRromatin Organisation MOdifier) domain
- Chromodomain-helicase-DNA-binding protein 6-9, tri-helical
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CHD6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
- NFE2L2
- PA
- PB2
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHD6 as an antibody target. Whether an autoantibody or antibody against CHD6 could matter depends on whether native CHD6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHD6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CHD6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...